SS
ANAB icon

SBI Securities’s AnaptysBio ANAB Stock Holding History

SBI Securities’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-788
Closed -$43.7K – 4072
2026
Q1 		$43.7K Sell
788
-1,046
-57% -$56.3K ﹤0.01% 1159
2025
Q4 		$88.9K Buy
1,834
+1,830
+45,750% +$71.3K ﹤0.01% 881
2025
Q3 		$122 Buy
4
+3
+300% +$69 ﹤0.01% 3466
2025
Q2 		$22 Sell
1
-9
-90% -$188 ﹤0.01% 3895
2025
Q1 		$186 Buy
10
+5
+100% +$83 ﹤0.01% 3245
2024
Q4 		$66 Buy
+5
New +$121 ﹤0.01% 3567

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

SBI Securities's ANAB Position: Q2 2026 in Review

SBI Securities sold out of AnaptysBio (ANAB) in Q2 2026, closing a stake of 788 shares — an estimated $43.7K sold.

SBI Securities first reported a position in ANAB in Q4 2024 and held it in 6 quarters. The position peaked at $88.9K in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • SBI Securities reported no remaining AnaptysBio position as of Q2 2026 after selling out during the quarter.
  • SBI Securities sold 788 AnaptysBio shares in Q2 2026, an estimated $43.7K.
  • SBI Securities first reported a position in AnaptysBio in Q4 2024 and held it in 6 quarters.
  • SBI Securities's AnaptysBio position peaked at $88.9K in Q4 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.